Guangdong VTR Bio-Tech Co's quarterly market cap
declined
from Sep. 2023 (¥3,626.6 Mil) to Dec. 2023 (¥3,611.9 Mil) and
declined
from Dec. 2023 (¥3,611.9 Mil) to Mar. 2024 (¥2,715.1 Mil).
Guangdong VTR Bio-Tech Co's annual market cap
declined
from Dec. 2021 (¥5,817.1 Mil) to Dec. 2022 (¥3,734.4 Mil) and
declined
from Dec. 2022 (¥3,734.4 Mil) to Dec. 2023 (¥3,611.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guangdong VTR Bio-Tech Co's Enterprise Value for Today is ¥2,862.9 Mil.
Guangdong VTR Bio-Tech Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Guangdong VTR Bio-Tech Co's Market Cap
For the Biotechnology subindustry, Guangdong VTR Bio-Tech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong VTR Bio-Tech Co's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Guangdong VTR Bio-Tech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Guangdong VTR Bio-Tech Co's Market Cap falls into.
Guangdong VTR Bio-Tech Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong VTR Bio-Tech Co (SZSE:300381) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Guangdong VTR Bio-Tech Co Market Cap Related Terms
Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300381 has been successfully added to your 